DEEPAK RAJPOOT: Open Payments
NPI 1093942864 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,233 in 20 payments from 3 companies in 2025. Trend: 2023 $29,496 · 2024 $49,005 · 2025 $30,233
Speaker / faculty: $29,639Food & beverage: $482Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $30,100 |
| Axsome Therapeutics, Inc. | 4 | $101 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $31 |
Products named: UZEDY, AUSTEDO XR, Auvelity, REJOYN.
Industry payments across CA — which companies pay providers there.
